Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Hisse Senetlerindeki Sıralama
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Hisse Fiyatı
$6.17
Piyasa Değeri
$3.52B
Değişim (1 gün)
-0.05%
Değişim (1 yıl)
-1.86%
Ülke
CN
Ticaret Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Kategori
Healthcare
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 18.33%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 18.33%'dir. 2024 yılı sonunda şirketin faaliyet marjı 35.13% idi.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited için 2001 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 18.33% | -63.80% |
| 2025 | 50.63% | 44.12% |
| 2024 | 35.13% | 163.34% |
| 2023 | 13.34% | 12.29% |
| 2022 | 11.88% | -5.34% |
| 2021 | 12.55% | 5.55% |
| 2020 | 11.89% | 9.59% |
| 2019 | 10.85% | 7.53% |
| 2018 | 10.09% | 9.08% |
| 2017 | 9.25% | 32.33% |
| 2016 | 6.99% | -0.85% |
| 2015 | 7.05% | 20.93% |
| 2014 | 5.83% | -13.50% |
| 2013 | 6.74% | 24.58% |
| 2012 | 5.41% | -12.46% |
| 2011 | 6.18% | -10.82% |
| 2010 | 6.93% | -4.55% |
| 2009 | 7.26% | 83.33% |
| 2008 | 3.96% | -167.69% |
| 2007 | -5.85% | -65.20% |
| 2006 | -16.81% | -1,112.65% |
| 2005 | 1.66% | -47.30% |
| 2004 | 3.15% | -30.46% |
| 2003 | 4.53% | -18.23% |
| 2002 | 5.54% | 4.92% |
| 2001 | 5.28% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 10.52% | -99.43% |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -98.75% |
IN
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.